Sandoz ordered to pay Lundbeck over $26.3M for infringing Lexapro patent
Intellectual Property 2019-02-19 10:18 pm By Christine Caulfield | Melbourne
Please login to bookmark Close

Generic drug maker Sandoz must pay $26.34 million to Danish pharmacuetical giant Lundbeck and a subsidiary for infringing the Australian patent behind the blockbuster antidepressant Lexapro, a judge has found.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au